Regeneron Pharmaceuticals
H-1B· Fiscal year 2026
Median H-1B salary
$154.9K
Middle 50% range
$123.6K – $180.7K
H-1B filings
305
Salary by experience level
Entry (I) · n=10$106.3K
Qualified (II) · n=174$145.0K
Experienced (III) · n=45$162.3K
Fully competent (IV) · n=69$184.5K
Salary by role
| Role | Median H-1B salary | n |
|---|---|---|
| Principal Scientist | $164.0K | 21 |
| Sr Scientist | $144.5K | 18 |
| Senior Scientist | $144.3K | 14 |
| Associate Scientist | $92.8K | 11 |
| Scientist | $115.0K | 9 |
| Sr Associate Scientist | $100.5K | 9 |
| Principal Statistical Programmer | $154.9K | 8 |
| Principal Biostatistician | $150.4K | 8 |
| Postdoctoral Fellow | $100.9K | 8 |
| Senior Associate Scientist | $101.8K | 7 |
Based on certified H-1B Labor Condition Applications (offered salaries of foreign workers). Not total compensation; stock and bonus are excluded.
Estimated take-home of this pay:$9.8K / month(Federal tax only — state and local taxes are not included)Calculate →
Quick read
- Average pay is 36% above the median of the companies we track.
- Ranks #217 of 1384 Services & Education companies in this country by pay.
- Revenue grew 1.0% year over year.
- Revenue has grown two years in a row.
- Operating margin was 24.9% in 2025.
- Senior (level IV) H-1B pay is 1.7× entry level (level I).
Last 3 years
Revenue
Operating income
Investor metrics
2025
- Operating margin
- 24.9%
- Net margin
- 31.4%
- ROE
- 14.4%
- Debt-to-equity
- 29.8%
- Equity ratio
- 77.1%